19.01.2012Advent Life Sciences Fund I welcomes additional investor

Advent Life Sciences is pleased to welcome the SNCI as an investor in Advent Life Sciences Fund I (ALSF I).  This now brings ALSF I to a final close of just under £100m.

Press Release

04.01.2012Cornerstone Therapeutics Acquires Cardiokine

Cornerstone acquires worldwide rights to investigational therapy for hyponatremia

Press Release